MOTHER FRİENDLY PRACTİCES AND MATERNAL, FETAL OUTCOMES

NCT07514195 | Completed DMC

• 1 other identifier: E-43012747-050.04-438233-43
• Study Type: observational
• Target: 281
• Locations: 1 country
• Sites: 1

Brief Summary

The "mother-friendly hospital" model aims to enhance care quality by avoiding unnecessary, non-evidence-based interventions and supporting natural physiological processes from early pregnancy to postpartum. This study evaluated the impact of mother-friendly hospital criteria on labor pain, maternal satisfaction, and maternal and fetal outcomes. Mother-friendly hospital practices emphasizing minimal intervention and physiologic support reduce labor pain, improve maternal satisfaction, and enhance neonatal outcomes. Implementing mother-friendly approaches ensures safe, high-quality, mother-centered maternity care. The results of our study showed that mother-friendly approaches increased maternal satisfaction during the childbirth process and reduced pain scores. These results revealed that mother-friendly practices not only improve the childbirth experience of women but also contribute positively to maternal and neonatal health. Therefore, supporting and expanding the integration of mother-friendly approaches into the healthcare system is of great importance for improving the quality of obstetric services.

Conditions

Delivery Care; Satisfaction With Care

Keywords

Maternal satisfaction; Mother-friendly; Maternal outcomes; Fetal outcomes

Outcome Measures

Primary Outcomes (1)

• Composite adverse maternal and neonatal outcome

  A composite outcome including at least one of the following: cesarean delivery, postpartum hemorrhage, severe perineal trauma, low 5-minute Apgar score (\<7), or NICU admission.

  From delivery to hospital discharge, 1. day

Study Arms (2)

Group 1

where mother-friendly approaches were implemented

Group 2

where mother-friendly approaches were not implemented

Eligibility Criteria

• Age: 18 Years - 45 Years
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64)
• Sampling Method: Probability Sample

Study Population

Pregnant women receiving care at participating centers, aged 18-45 years, with singleton pregnancies at ≥37 weeks of gestation. Participants must be planning to deliver at the study hospital and provide informed consent. Women with multiple gestations, major maternal comorbidities (e.g., pre-existing diabetes, hypertension, cardiac disease), or known fetal anomalies are excluded. The study population represents a prospective cohort of patients exposed to routine mother-friendly practices in a multicenter clinical setting.

You may qualify if:

• Patients aged 18-45
• No chronic diseases
• No acute illnesses
• No pregnancy complications
• Spontaneous pregnancy
• Full-term pregnancy
• Appropriate-for-gestational-age (AGA) infants

You may not qualify if:

• Individuals over 45 years of age
• Maternal type 1 and 2 diabetes mellitus or gestational diabetes
• Chronic hypertension
• Preeclampsia
• Connective tissue disease
• Smoking during pregnancy
• Preterm birth (gestational age \<37 weeks)
• small-for-gestational-age infants (birth weight \< 2 SD)
• neonatal asphyxia (APGAR score \<7 at 1 and 5 minutes)
• malformations, chromosomal disorders, and congenital infections
• women with signs of chorioamnionitis (fever, leukocytosis, abdominal pain, foul-smelling discharge) more than 12 hours after EMR
• chronic kidney and liver disease
• hematological disorders
• Should not be administered to individuals with a pacemaker
• Should not be administered to patients with epilepsy, transient ischemic attacks, or a history of cerebrovascular events

Sponsors & Collaborators

• Sakarya University: lead

Study Sites (1)

The Obstetrics Clinics of Sakarya Research and Training Hospital

Sakarya, Adapazarı, Turkey (Türkiye)

Location

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 30, 2026
• First Posted: April 7, 2026
• Study Start: February 28, 2025
• Primary Completion: July 31, 2025
• Study Completion: September 30, 2025
• Last Updated: April 13, 2026

Record last verified: 2026-04

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)